Gravitate Health FHIR Implementation Guide
0.1.0 - CI Build

Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health/ and changes regularly. See the Directory of published versions

Example Composition: Composition for Biktarvy 50 mg/200 mg/25 mg film-coated tablets Package Leaflet

Generated Narrative: Composition composition-proc-es-1846d2b12fecbbb0310cd8c196c98f82

Language: es

Profile: Composition (ePI)

HtmlElementLink

  • elementClass: indication
  • concept: HIV-infection/AIDS

HtmlElementLink

  • elementClass: pregnancyCategory
  • concept: Pregnancy

HtmlElementLink

  • elementClass: breastfeedingCategory
  • concept: Normal breast feeding (finding)

HtmlElementLink

  • elementClass: liver
  • concept: Liver disease, other

HtmlElementLink

  • elementClass: contra-indication-hypericum
  • concept: Hypericum perforatum L.

HtmlElementLink

  • elementClass: hepatitisB
  • concept: Viral hepatitis type B (disorder)

identifier: https://spor.ema.europa.eu/rmswi//b22ec2e7263c64ba0d74e2718a1859op

status: Final

type: Package Leaflet

category: processed

date: 2022-02-16 13:28:17+0000

​author: Bundle: identifier = https://www.gravitatehealth.eu/sid/doc#EU/1/18/1289/001; type = document; timestamp = 2023-06-27 10:09:22+0000

title: TEST PURPOSES ONLY - Biktarvy 50 mg/200 mg/25 mg film-coated tablets

Attesters

-ModeTime
*Official2022-02-16 13:28:17+0000